PDS Health, one of the largest dental support organizations in the United States with more than 1,100 practices, has selected Pearl as its enterprise AI partner for radiologic decision support. The announcement, made on February 3, 2026, follows what the company described as a “comprehensive evaluation of the dental AI landscape.”
The full enterprise rollout will bring Pearl’s FDA-cleared AI platform to every PDS Health location, marking one of the largest single-DSO deployments of clinical AI technology to date.
What the Deployment Covers
PDS Health, headquartered in Henderson, Nevada, will deploy Pearl’s real-time radiologic support tools across its entire network. The platform is designed to assist clinicians with earlier identification of areas of concern, improve diagnostic consistency across locations, and provide real-time chairside image review with visual indicators that help patients understand their oral health.
A distinguishing feature of the Pearl platform is its support for both traditional radiographic imaging and advanced 3D imaging, including cone-beam computed tomography (CBCT). That breadth of imaging coverage was likely a factor in PDS Health’s selection, as DSOs operating at scale increasingly rely on CBCT for implant planning, endodontics, and complex diagnostics.
In addition to chairside tools, the deployment includes practice-level reporting capabilities, giving PDS Health leadership visibility into diagnostic patterns and clinical performance across its network of offices.
Pearl’s Growing DSO Footprint
The PDS Health deal significantly expands Pearl’s enterprise presence. Founded by Ophir Tanz, the company closed a $40 million Series B round from Morpheus Ventures in late 2025, capital that has fueled an aggressive push into the DSO market.
Pearl has announced several major DSO partnerships in quick succession. In January 2026, Coast Dental signed on for a deployment across its 88 practices. In February 2026, DECA Dental committed to Pearl across approximately 200 locations. Combined with the PDS Health rollout, Pearl’s DSO footprint now spans roughly 1,388 or more locations.
That rapid growth signals strong demand among large dental groups for AI-assisted radiologic review, and it places Pearl firmly in the top tier of clinical AI vendors competing for enterprise contracts.
A Historic Day for Dental AI Adoption
The timing of the PDS Health announcement is remarkable. On the same day — February 3, 2026 — Aspen Dental announced its own enterprise AI deployment with VideaHealth, another leading clinical AI platform. Aspen Dental also operates more than 1,100 locations.
Two mega-DSOs with over 1,100 practices each making enterprise AI commitments on the same day is unprecedented and underscores how quickly the industry’s largest players are moving to standardize AI-assisted clinical workflows.
The Competitive Landscape in Clinical AI
The dental clinical AI market is now defined by three major vendors — Overjet, Pearl, and VideaHealth — each pursuing a distinct strategy to capture enterprise DSO contracts.
VideaHealth currently leads in total DSO footprint with an estimated 4,260 or more locations under contract, bolstered by its Aspen Dental partnership and other deployments. Overjet has secured enterprise deals with Sonrava Health (450+ locations), Dental Care Alliance (400+ locations), and North American Dental Group (216 locations), among others.
Pearl differentiates itself through its CBCT and 3D imaging capabilities, a feature set that neither Overjet nor VideaHealth has matched at the same scale. For DSOs with significant implant, orthodontic, or oral surgery volumes, that 3D imaging support may prove to be a decisive factor.
The pace of enterprise announcements in early 2026 suggests the window for winning major DSO contracts is narrowing. With the three largest clinical AI vendors all actively expanding, mid-market DSOs that have been evaluating options may face increasing pressure to commit.
What It Means for PDS Health
For PDS Health, the Pearl deployment represents a significant investment in clinical technology infrastructure. Standardizing AI-assisted radiologic review across more than 1,100 practices is a logistically complex undertaking, but it offers several potential advantages: more consistent diagnostic quality across locations, better patient communication through visual chairside tools, and centralized reporting that supports quality assurance at scale.
The decision also positions PDS Health alongside Aspen Dental as one of the first mega-DSOs to formalize an enterprise AI commitment — a distinction that may carry weight in clinician recruitment, patient trust, and competitive positioning as the industry continues to evolve.
Looking Ahead
The simultaneous announcements from PDS Health and Aspen Dental mark a turning point for AI adoption in organized dentistry. The question is no longer whether the largest DSOs will adopt clinical AI, but how quickly the technology will become a baseline expectation across the industry.
As Pearl, VideaHealth, and Overjet continue to compete for enterprise contracts, the next frontier may be integration — connecting clinical AI insights with practice management systems, patient engagement platforms, and operational analytics to deliver a more unified technology experience across the dental enterprise.